Good COPs or Bad COPs: Advocacy to Ensure the Prioritization of TB in 2018 PEPFAR Country Operational Plans (COPs). Every year, PEPFAR meets to discuss their strategy and budget for the following year, and set targets on implementing country operation…
Note that the following PDFs listed at the top of this page were handouts shared with the Webinar: --Phase III Clinical Trial Results at the 48th Union World Conference on Lung Health: Implications for the Field1, PDF --TB CAB's Proposed…
On October 12, 2017, in Guadalajara, Mexico, Treatment Action Group, Advanced Access & Delivery, Harvard Medical School, Partners In Health, and the Stop TB Partnership sponsored a symposium in conjunction with the Union World Conference on Lung Health. Introduction -…
On November 29, 2017, Treatment Action Group (TAG) hosted a webinar on suboptimal immune recovery despite HIV suppression by antiretroviral therapy. Presented by Richard Jefferys, TAG’s Basic Science, Vaccines and Cure Project Director, the webinar reviewed the possible causes and…
Remarks by Erica Lessem, Deputy Executive Director – TB Project Global Ministerial Conference on Ending TB in the Sustainable Development Era Moscow, Russian Federation November 17, 2017 Using lessons learnt from HIV, how do you see civil society and advocacy…
The United Nations High Level Meeting (HLM) on TB is rapidly approaching. The U.N. HLM on TB will take place on September 26, 2018 during the second day of general debate of the General Assembly at its seventy-third session…
TAG and partners hosted this webinar on October 3, 2017. Speakers included Lynette Mabote, AIDS & Rights Alliance for Southern Africa; Lindiwe Mvusi, Department of Health, Republic of South Africa; Stephen Wanjala, MSF; and Wayne van Gemert, Global Drug Facility…
On Monday, October 2, 2017, Treatment Access Group joined National Viral Hepatitis Roundtable and the Hepatitis Education Project to present this update on HCV DAA treatment access in the U.S. prison system. The webinar included information about newly available treatments,…
Objectives for Module 1: Discuss the difference between HIV prevention for HIV-negative people, HIV prevention for people living with HIV, and HIV testing Discuss the evidence-based HIV prevention options we have available Overview of new tools in development In many…
Objectives for Module 2: Discuss what HEALTH INDICATORS are, what they are not, and why they are important Look at some of the current indicators and relevant research to see how well we’re doing with HIV prevention in key populations…